KMDA Kamada Ltd
Price (delayed)
$6.42
Market cap
$369.18M
P/E Ratio
25.68
Dividend/share
$0.2
EPS
$0.25
Enterprise value
$301.81M
kamada ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. the company uses its proprietary platform technology
Highlights
The company's gross profit rose by 26% YoY and by 3.9% QoQ
KMDA's revenue is up by 13% year-on-year
KMDA's net income has soared by 75% year-on-year but it is down by 8% since the previous quarter
Kamada's EPS has increased by 47% YoY but it has decreased by 14% QoQ
The price to earnings (P/E) is 26% higher than the last 4 quarters average of 20.6
Kamada's debt has increased by 25% YoY
Key stats
What are the main financial stats of KMDA
Market
Valuations
Earnings
Shares outstanding
57.51M
Market cap
$369.18M
Enterprise value
$301.81M
Price to earnings (P/E)
25.68
Price to book (P/B)
1.42
Price to sales (P/S)
2.29
EV/EBIT
21.57
EV/EBITDA
10.86
EV/Sales
1.88
Revenue
$160.95M
Gross profit
$69.97M
Operating income
$20.05M
Net income
$14.46M
EBIT
$13.99M
EBITDA
$27.8M
Free cash flow
$36.86M
Per share
Balance sheet
Liquidity
EPS
$0.25
EPS diluted
$0.25
Free cash flow per share
$0.64
Book value per share
$4.51
Revenue per share
$2.8
TBVPS
$4.15
Total assets
$372.26M
Total liabilities
$112.79M
Debt
$11.06M
Equity
$259.46M
Working capital
$134.96M
Debt to equity
0.04
Current ratio
3.73
Quick ratio
2.14
Net debt/EBITDA
-2.42
Margins
Efficiency
Dividend
EBITDA margin
17.3%
Gross margin
43.5%
Net margin
9%
Operating margin
12.5%
Return on assets
4.1%
Return on equity
5.7%
Return on invested capital
11.3%
Return on capital employed
4.3%
Return on sales
8.7%
Dividend yield
3.12%
DPS
$0.2
Payout ratio
80%
KMDA stock price
How has the Kamada stock price performed over time
Intraday
-1.23%
1 week
2.23%
1 month
-4.46%
1 year
27.13%
YTD
5.42%
QTD
-2.87%
Financial performance
How have Kamada's revenue and profit performed over time
Revenue
$160.95M
Gross profit
$69.97M
Operating income
$20.05M
Net income
$14.46M
Gross margin
43.5%
Net margin
9%
Kamada's operating income has soared by 99% YoY and by 19% from the previous quarter
KMDA's operating margin has surged by 76% year-on-year and by 18% since the previous quarter
KMDA's net income has soared by 75% year-on-year but it is down by 8% since the previous quarter
Kamada's net margin has soared by 55% YoY but it has decreased by 9% from the previous quarter
Growth
What is Kamada's growth rate over time
Valuation
What is Kamada stock price valuation
P/E
25.68
P/B
1.42
P/S
2.29
EV/EBIT
21.57
EV/EBITDA
10.86
EV/Sales
1.88
Kamada's EPS has increased by 47% YoY but it has decreased by 14% QoQ
The price to earnings (P/E) is 26% higher than the last 4 quarters average of 20.6
The stock's price to book (P/B) is 11% more than its 5-year quarterly average of 1.3 and 11% more than its last 4 quarters average of 1.3
KMDA's equity is up by 6% year-on-year
KMDA's P/S is 16% above its 5-year quarterly average of 2.0 and 16% above its last 4 quarters average of 2.0
KMDA's revenue is up by 13% year-on-year
Efficiency
How efficient is Kamada business performance
KMDA's return on assets has surged by 64% year-on-year but it is down by 9% since the previous quarter
KMDA's return on equity is up by 43% year-on-year but it is down by 10% since the previous quarter
Kamada's return on sales has increased by 28% YoY but it has decreased by 16% QoQ
The company's return on invested capital rose by 26% YoY but it fell by 15% QoQ
Dividends
What is KMDA's dividend history
DPS
$0.2
Dividend yield
3.12%
Payout ratio
80%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Kamada financials performed over time
KMDA's quick ratio is up by 30% year-on-year but it is down by 22% since the previous quarter
Kamada's current ratio has decreased by 23% from the previous quarter but it has increased by 9% YoY
Kamada's debt is 96% less than its equity
Kamada's debt has increased by 25% YoY
KMDA's equity is up by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.